These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 9973220
1. Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas-induced apoptosis. Gutiérrez MI, Cherney B, Hussain A, Mostowski H, Tosato G, Magrath I, Bhatia K. Cancer Res; 1999 Feb 01; 59(3):696-703. PubMed ID: 9973220 [Abstract] [Full Text] [Related]
2. Potential mechanism of resistance to TRAIL-induced apoptosis in Burkitt's lymphoma. Tafuku S, Matsuda T, Kawakami H, Tomita M, Yagita H, Mori N. Eur J Haematol; 2006 Jan 01; 76(1):64-74. PubMed ID: 16343273 [Abstract] [Full Text] [Related]
3. Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell lines. Röth A, Pfaff P, Lange W, Finke J. Cytokines Mol Ther; 1996 Mar 01; 2(1):21-8. PubMed ID: 9384686 [Abstract] [Full Text] [Related]
4. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. Fulda S, Meyer E, Debatin KM. Cancer Res; 2000 Jul 15; 60(14):3947-56. PubMed ID: 10919673 [Abstract] [Full Text] [Related]
5. Azidothymidine and interferon-alpha induce apoptosis in herpesvirus-associated lymphomas. Lee RK, Cai JP, Deyev V, Gill PS, Cabral L, Wood C, Agarwal RP, Xia W, Boise LH, Podack E, Harrington WJ. Cancer Res; 1999 Nov 01; 59(21):5514-20. PubMed ID: 10554028 [Abstract] [Full Text] [Related]
6. Fas-mediated apoptosis in human prostatic carcinoma cell lines. Rokhlin OW, Bishop GA, Hostager BS, Waldschmidt TJ, Sidorenko SP, Pavloff N, Kiefer MC, Umansky SR, Glover RA, Cohen MB. Cancer Res; 1997 May 01; 57(9):1758-68. PubMed ID: 9135020 [Abstract] [Full Text] [Related]
7. Differential responses to CD40 ligation among Burkitt lymphoma lines that are uniformly responsive to Epstein-Barr virus latent membrane protein 1. Henriquez NV, Floettmann E, Salmon M, Rowe M, Rickinson AB. J Immunol; 1999 Mar 15; 162(6):3298-307. PubMed ID: 10092782 [Abstract] [Full Text] [Related]
8. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins. Blood A, Edwards CJ, Ishii HH, Pat BK, Bryson G, Sculley TB, Gobe GC. Arch Virol; 2004 Feb 15; 149(2):289-302. PubMed ID: 14745596 [Abstract] [Full Text] [Related]
9. Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma. Toomey NL, Deyev VV, Wood C, Boise LH, Scott D, Liu LH, Cabral L, Podack ER, Barber GN, Harrington WJ. Oncogene; 2001 Oct 25; 20(48):7029-40. PubMed ID: 11704827 [Abstract] [Full Text] [Related]
10. Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells. Walker A, Taylor ST, Hickman JA, Dive C. Cancer Res; 1997 May 15; 57(10):1939-45. PubMed ID: 9157989 [Abstract] [Full Text] [Related]
11. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder. Roychowdhury S, Baiocchi RA, Vourganti S, Bhatt D, Blaser BW, Freud AG, Chou J, Chen CS, Xiao JJ, Parthun M, Chan KK, Eisenbeis CF, Ferketich AK, Grever MR, Chen CS, Caligiuri MA. J Natl Cancer Inst; 2004 Oct 06; 96(19):1447-57. PubMed ID: 15467034 [Abstract] [Full Text] [Related]
12. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies. Abdulkarim B, Sabri S, Zelenika D, Deutsch E, Frascogna V, Klijanienko J, Vainchenker W, Joab I, Bourhis J. Oncogene; 2003 Apr 17; 22(15):2260-71. PubMed ID: 12700662 [Abstract] [Full Text] [Related]
13. Anti-CD20- and B-cell receptor-mediated apoptosis: evidence for shared intracellular signaling pathways. Mathas S, Rickers A, Bommert K, Dörken B, Mapara MY. Cancer Res; 2000 Dec 15; 60(24):7170-6. PubMed ID: 11156427 [Abstract] [Full Text] [Related]
14. Up-regulation of Bcl-xL expression protects CD40-activated human B cells from Fas-mediated apoptosis. Zhang X, Li L, Choe J, Krajewski S, Reed JC, Thompson C, Choi YS. Cell Immunol; 1996 Oct 10; 173(1):149-54. PubMed ID: 8871610 [Abstract] [Full Text] [Related]
15. Role of bcl-2 in Epstein-Barr virus-induced malignant conversion of Burkitt's lymphoma cell line Akata. Komano J, Takada K. J Virol; 2001 Feb 10; 75(3):1561-4. PubMed ID: 11152530 [Abstract] [Full Text] [Related]
16. A recessive mutant of the U937 cell line acquired resistance to anti-Fas and anti-p55 tumor necrosis factor receptor antibody-induced apoptosis. Noguchi K, Naito M, Kataoka S, Yonehara S, Tsuruo T. Cell Growth Differ; 1995 Oct 10; 6(10):1271-7. PubMed ID: 8845304 [Abstract] [Full Text] [Related]
17. Follicular dendritic cells protect malignant B cells from apoptosis induced by anti-Fas and antineoplastic agents. Schwarz YX, Yang My, Qin D, Wu J, Jarvis WD, Grant S, Burton GF, Szakal AK, Tew JG. J Immunol; 1999 Dec 15; 163(12):6442-7. PubMed ID: 10586034 [Abstract] [Full Text] [Related]
18. Cycloheximide and actinomycin D delay death and affect bcl-2, bax, and Ice gene expression in astrocytes under in vitro ischemia. Yu AC, Yung HW, Hui MH, Lau LT, Chen XQ, Collins RA. J Neurosci Res; 2003 Oct 15; 74(2):318-25. PubMed ID: 14515361 [Abstract] [Full Text] [Related]
19. Ectopic expression of Bcl-2, but not Bcl-xL rescues Ramos B cells from Fas-mediated apoptosis. Alam MK, Davison S, Siddiqui N, Norton JD, Murphy JJ. Eur J Immunol; 1997 Dec 15; 27(12):3485-91. PubMed ID: 9464838 [Abstract] [Full Text] [Related]
20. Identification of p21 as a target of cycloheximide-mediated facilitation of CD95-mediated apoptosis in human malignant glioma cells. Glaser T, Wagenknecht B, Weller M. Oncogene; 2001 Aug 09; 20(35):4757-67. PubMed ID: 11521188 [Abstract] [Full Text] [Related] Page: [Next] [New Search]